10.46 -0.58 (-5.34%)
ALKS
Stock Details
Last Trade:10.46 Change:-0.58 (-5.34%) Prev Close:11.04 Open: 10.87 Days Range:10.29 – 10.89 52 Week Range: 5.55 - 17.05 Volume:858448 P/E: 7.69EPS:1.36
View AllRecent Alerts 07/04/09
Recent Alert on 06/08/09 at 7:01am
Amylin (AMLN), Eli Lilly (LLY) and Alkermes (ALKS) Said Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control with Weight Loss Over Two Years
Amylin (AMLN), Eli Lilly (LLY) and Alkermes (ALKS) Said Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control with Weight Loss Over Two Years
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY), and Alkermes, Inc. (Nasdaq: ALKS) announced long-term, interim results from the DURATION-1 study that showed sustained glucose control with weight loss, as well as... Read More
Recent Alert on 05/20/09 at 3:22pm
Trading Radar for 5/21: Gap (GPS), salesforce.com (CRM), GameStop (GME), Suntech (STP), LDK Solar (LDK), Autodesk (ADSK), Buckle (BKE), Excel Maritime (EXM) Report; Initial Claims Due
Trading Radar for 5/21: Gap (GPS), salesforce.com (CRM), GameStop (GME), Suntech (STP), LDK Solar (LDK), Autodesk (ADSK), Buckle (BKE), Excel Maritime (EXM) Report; Initial Claims Due
Recent Alert on 05/18/09 at 8:40am
FDA Grants Approval for Use of Alkermes (ALKS) RISPERDAL CONSTA as Both a Monotherapy and Adjunctive Therapy in the Maintenance Treatment of Bipolar I Disorder
FDA Grants Approval for Use of Alkermes (ALKS) RISPERDAL CONSTA as Both a Monotherapy and Adjunctive Therapy in the Maintenance Treatment of Bipolar I Disorder
Recent Alert on 05/18/09 at 8:40am
FDA Grants Approval for Use of Alkermes (ALKS) RISPERDAL CONSTA as Both a Monotherapy and Adjunctive Therapy in the Maintenance Treatment of Bipolar I Disorder
FDA Grants Approval for Use of Alkermes (ALKS) RISPERDAL CONSTA as Both a Monotherapy and Adjunctive Therapy in the Maintenance Treatment of Bipolar I Disorder
Recent Alert on 05/05/09 at 10:12am
Morning Movers 5/5: CALL, CTIC, ATRC, PEGA, ACAD Higher; HLIT, HOLX, DW, PQ, MYGN Lower
Morning Movers 5/5: CALL, CTIC, ATRC, PEGA, ACAD Higher; HLIT, HOLX, DW, PQ, MYGN Lower
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
View AllRecent Blog Posts
Blog Posts on 06/28/09 at 7:47am
30 Possible Pandemic Profit Plays: Bullish Biotech and Drug Stocks to Watch
30 Possible Pandemic Profit Plays: Bullish Biotech and Drug Stocks to Watch
Blog Posts on 06/02/09 at 8:43am
Biotech Opportunities: Look for Decent Pipeline, Big Pharma Partnerships
Biotech Opportunities: Look for Decent Pipeline, Big Pharma Partnerships